Abstract
An 18-year-old man with Crohn disease developed a pruritic eruption involving the genital and inguinal areas during adalimumab therapy. This Clinicopathological Case highlights the importance of clinicopathological correlation and site-specific assessment of genital eruptions in patients receiving anti-TNF therapy.